13F-HR filed by Redmile Group, LLC
Redmile Group, LLC filed this 13F-HR for the quarter ended 2015-06-30, filed 2015-08-14, with 55 holding rows worth $1,220,166,000.
- Accession
- 0001425738-15-000017
- Filer
- CIK 1425738
- Filed
- 2015-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2015
A holdings report, 55 entries on the cover page, a total value of $1,220,166,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,220,168,000 with VALUE read as thousands by filing date, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 13,623,620 | $98,226,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 6,297,523 | $89,110,000 | thousands by filing date | |
| VALEANT PHARMACEUTICALS INTL | 91911K102 | COM | 384,506 | $85,418,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 759,479 | $66,743,000 | thousands by filing date | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 967,359 | $57,171,000 | thousands by filing date | |
| ALLERGAN PLC | G0177J108 | SHS | 136,818 | $41,519,000 | thousands by filing date | |
| KYTHERA BIOPHARMACEUTICALS I | 501570105 | COM | 482,556 | $36,341,000 | thousands by filing date | |
| HCA Healthcare Inc | 40412C101 | COM | 390,000 | $35,381,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 510,010 | $34,268,000 | thousands by filing date | |
| AETNA INC NEW | 00817Y108 | COM | 264,075 | $33,659,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 699,425 | $32,313,000 | thousands by filing date | |
| CIGNA CORPORATION | 125509109 | COM | 198,700 | $32,189,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 79,118 | $31,959,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 207,744 | $28,415,000 | thousands by filing date | |
| RECEPTOS, INC. | 756207106 | COMMON STOCK | 144,205 | $27,406,000 | thousands by filing date | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 150,866 | $26,563,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 529,199 | $25,613,000 | thousands by filing date | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 175,965 | $25,005,000 | thousands by filing date | |
| Lowes Companies Inc | 42222G108 | LOW | 388,128 | $24,887,000 | thousands by filing date | |
| ALERE INC | 01449J105 | COM | 461,170 | $24,327,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 1,459,742 | $22,509,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 290,350 | $21,196,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 867,346 | $21,181,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 372,642 | $19,661,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 610,171 | $19,495,000 | thousands by filing date | |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 146,027 | $17,938,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 164,995 | $17,194,000 | thousands by filing date | |
| MODEL N INC | 607525102 | COM | 1,443,278 | $17,189,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 1,212,892 | $16,799,000 | thousands by filing date | |
| CASTLIGHT HEALTH INC CL B | 14862Q100 | Stock | 1,984,631 | $16,155,000 | thousands by filing date | |
| ZS PHARMA INC | 98979G105 | Common Stock | 302,988 | $15,874,000 | thousands by filing date | |
| ONCOTHYREON INC | 682324108 | COM | 4,164,878 | $15,577,000 | thousands by filing date | |
| CIVITAS SOLUTIONS INC | 17887R102 | COM | 657,693 | $14,029,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 2,007,446 | $12,988,000 | thousands by filing date | |
| DAVITA INC COM | 23918K108 | Stock | 140,191 | $11,141,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 378,235 | $9,671,000 | thousands by filing date | |
| AVALANCHE BIOT | 05337G107 | Common Stock | 537,282 | $8,725,000 | thousands by filing date | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 516,690 | $8,613,000 | thousands by filing date | |
| GENOCEA BIOSCIENCES INC | 372427104 | COM | 623,519 | $8,561,000 | thousands by filing date | |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 348,237 | $8,427,000 | thousands by filing date | |
| CERUS CORP | 157085101 | COM | 1,603,427 | $8,322,000 | thousands by filing date | |
| TRIVASCULAR TECHNOLOGIES INC | 89685A102 | COM | 1,464,563 | $7,835,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 152,700 | $6,955,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 67,425 | $6,904,000 | thousands by filing date | |
| BELLICUM PHARMACEUTICALS INC | 079481107 | COM | 238,121 | $5,065,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC | 04269XAA3 | NOTE 3.000% 6/0 | 4,000,000 | $5,050,000 | thousands by filing date | principal |
| CHEMOCENTRYX INC | 16383L106 | COM | 476,293 | $3,920,000 | thousands by filing date | |
| SESEN BIO, INC. | 286221106 | COM | 1,261,260 | $3,557,000 | thousands by filing date | |
| FLEXION THERAPEUTICS INC | 33938J106 | COM | 142,483 | $3,119,000 | thousands by filing date | |
| AXOVANT SCIENCES LTD | G0750W104 | COM | 150,000 | $3,057,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 181,224 | $2,563,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC. | 00739L101 | Common Stock | 61,639 | $1,870,000 | thousands by filing date | |
| ISHARES TR | 464288828 | US HLTHCR PR ETF | 8,599 | $1,229,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B103 | COM | 32,765 | $826,000 | thousands by filing date | |
| MARKET VECTORS PHARM ETF T | 57060U217 | ETF | 6,500 | $460,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001425738-15-000017 | this filing | 2015-08-14 | acceptance time not in the bulk data set |